Please assess the completion status of the following clinical trial:

Trial Title: Discovering FFC-MRI Biomarkers of Alzheimer Disease

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with probable Alzheimer's disease, based upon cognitive testing (MMSE) and SPECT imaging.~* Controls will be participants without known cognitive impairment or Alzheimer's disease.~* Subjects capable of giving informed consent.~* Age 21 and above~Exclusion Criteria:~* MRI-incompatible condition detected in the MR screening sheet such as some metallic implanted devices (see MR screening sheet in the project files).~* Claustrophobia~* Waist circumference larger than 102 cm, due to the limited bore size of the scanner.~* Restrictions to mobility such that patients are unable to be positioned in scanner by trained research radiographer e.g. severe kyphosis~* Cognitive impairment of sufficient severity that the participant does not have capacity to give informed consent~* Pregnancy~* Persons who might not adequately understand verbal explanations or written information given in English, or who have special communication needs~* Dementia of sufficient severity that the participant cannot give informed consent

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 120 Years
- Healthy Volunteers: t

Study Arms:
- Alzheimer's patients (Type: EXPERIMENTAL): Patient diagnosed with early onset Alzheimer's disease.
- Control (Type: ACTIVE_COMPARATOR): Healthy volunteers that do not have Alzheimer's disease.

Based on this trial design, predict the completion outcome and termination type (if applicable).